Top 10 fastest vaccine developing for coronavirus in the world

Nowadays, every country looking for coronavirus vaccine some vaccines are approved for limited use in a few countries. Some vaccines are in Phase 3 trials.

list of Top 10 fastest coronavirus (covid - 19) vaccines

Name - Gam-Covid-Vac.

Company name - Gamaleya Research Institute

Origin country name – Russia

Status – Phase 3, Approved for early use in Russia

Vaccine type - Viral vector Vaccine

On Aug. 11, President Vladimir V. Putin announced that a Russian health care regulator had approved the vaccine, renamed Sputnik V, before Phase 3 trials had even begun.

Name - CanSino

Company name – CanSino Biologics

Origin country name – China

Status – Phase 3, Approved for early use in china

Vaccine type - Viral vector Vaccine

The Chinese military approved the vaccine on June 25 for a year as a “specially needed drug.” CanSino would not say whether vaccination would be mandatory or optional for soldiers.

Name - EpiVacCorona

Company name – Vector Institute

Origin country name – Russia

Status – Phase 1, Phase 2, Combined phase, Approved for early use in Russia.

Vaccine type - Viral vector Vaccine

Vladimir Putin announced that Russia has granted regulatory approval to EpiVacCorona, making it the second vaccine to receive that designation after the Gamelaya Institute’s Sputnik V vaccine. Like the Sputnik vaccine, EpiVacCorona received approval before a Phase 3 trial to demonstrate that it was safe and effective.

Name - Sinopharm

Company name – Wuhan Institute of Biological Products

Origin country name – China

Status – Phase 3, Approved for limited use in U.A.E.

Vaccine type – Inactivated or Attenuated coronavirus Vaccine.

The Phase 1/2 trial showed that the vaccine produced antibodies in volunteers, some of whom experienced fevers and other side effects.

On Sept. 14, the U.A.E. gave emergency approval for Sinopharm’s vaccine to use on health care workers.

Name – Sinopharm (2)

Company name – Beijing Institute of Biological Products

Origin country name – China

Status – Phase 3, Approved for limited use in U.A.E.

Vaccine type – Inactivated or Attenuated coronavirus Vaccine.

After running early clinical trials in China, they launched Phase 3 trials in the United Arab Emirates and Argentina. Over the summer, the company later said, the government gave it approval to inject hundreds of thousands of people with its two experimental vaccines.

Name – CoronaVac

Company name – Sinovac Biotech

Origin country name – China

Status – Phase 3, Approved for limited use in china

Vaccine type – Inactivated or Attenuated coronavirus Vaccine.

In June the company announced that Phase 1/2 trials on 743 volunteers found no severe adverse effects and produced an immune response.

A Phase 3 trial in Brazil in July, followed by others in Indonesia and Turkey.

Name – Moderna

Company name – National Institutes of Health.

Origin country name – USA

Status – Phase 3

Vaccine type – Genetic Vaccine

On Aug. 11, the United States government awarded the company an additional $1.5 billion in exchange for 100 million doses if the vaccine proves safe and effective. Moderna has made similar deals with Canada, Japan, and Qatar.

Name – Covaxin

Company name – Indian Council of Medical Research, National Institute of Virology , Bharat Biotech .

Origin country name – India

Status – Phase 3

Vaccine type – Inactivated or Attenuated coronavirus Vaccine.

Reports circulated that the vaccine would be ready by Aug. 15. But the C.E.O. of Bharat told reporters it would be available no sooner than early 2021. On Oct. 23, the company announced they were initiating a Phase 3 trial.

Name – Johnson & Johnson

Company name – Beth Israel Deaconess Medical Center

Origin country name – USA

Status –Phase 3

Vaccine type – Viral vector vaccine

In August, the federal government agreed to pay $1 billion for 100 million doses if the vaccine is approved. The European Union reached a similar deal on Oct. 8 for 200 million doses. The company is aiming for production of at least a billion doses in 2021.

10.

Name – Novavax

Company name – Novavax

Origin country name – USA

Status – Phase 3

Vaccine type – Protein based vaccine

If the trials succeed, Novavax expects to deliver 100 million doses for use in the United States by the first quarter of 2021. In September Novavax reached an agreement with the Serum Institute of India, a major vaccine manufacturer, that they said would enable them to produce as many as 2 billion doses a year.